Akt- and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment

Molecular Medicine Reports

Volumn 1, Issue 1, 2008, Pages 83-88

  Su, Jin Cho ^a,b   Moon, Jung Chae ^b   Bong, Kyung Shin ^a,b   Han, Kyeom Kim ^a,b   Kim, Aeree ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Akt; Breast cancer; Heregulin; MAPK; Matrix metalloproteinase 9

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE B;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; STROMA CELL;

EID: 69249097943     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Malemud CJ: Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: 1696-1701, 2006. (Pubitemid 43253387)
2. Cho YB, Lee YW, Song SY, Shin HJ, Yun SH and Chun HK: Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer. Hum Pathol (In press).
3. Gimeno-García AZ, Santana-Rodríguez A, Jiménez A, et al: Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence. Eur J Cancer 42: 3246-3252, 2006. (Pubitemid 44854506)
4. Patel BP, Shah SV, Shukla SN, Shah PM and Patel PS: Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29: 564-572, 2007. (Pubitemid 47324773)
5. O-Charoenrat P, Wongkajornsilp A, Rhys-Evans PH and Eccles SA: Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells. Int J Cancer 111: 174-183, 2004. (Pubitemid 38924693)
6. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
7. Arteaga CL, Moulder SL and Yakes FM: HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer. Semin Oncol 29: 4-10, 2002. (Pubitemid 34816060)
8. Riese DJ II and Stern DF: Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20: 41-48, 1998.
9. Graus-Porta D, Beerli RR, Daly JM and Hynes NE: ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647-1655, 1997. (Pubitemid 27151960)
10. Holbro T, Beerli RR, Maurer F, et al: The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci USA 100: 8933-8938, 2003. (Pubitemid 36899201)
11. Chang HW, Aoki M, Fruman D, et al: Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276: 1848-1850, 1977.
12. Hermanto U, Zong CS and Wang LH: ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth. Oncogene 20: 7551-7562, 2001. (Pubitemid 33086915)
13. Pearson G, Robinson F, Beers Gibson T, et al: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183, 2001. (Pubitemid 32458157)
14. Cho SJ, La M, Ahn JK, Meadows GG and Joe CO: Tobmediated cross-talk between MARCKS phosphorylation and ErbB-2 activation. Biochem Biophys Res Commun 283: 273-277, 2001.
15. Anzick SL, Kononen J, Walker RL, et al: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968, 1997. (Pubitemid 27366683)
16. Riese DJ II, van Raaij TM, Plowman GD, Andrews GC and Stern DF: The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 15: 5770-5776, 1995.
17. De Fazio A, Chiew YE, Sini RL, Janes PW and Sutherland RL: Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. Int J Cancer 87: 487-498, 2000.
18. Schmitt M, Walker MP, Richards RG, et al: Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors. Mol Carcinog 45: 490-505, 2006.
19. Way TD and Lin JK: Role of HER2/HER3 co-receptor in breast carcinogenesis. Future Oncol 1: 841-849, 2005.
20. Kim A, Liu B, Ordonez-Ercan D, et al: Functional interaction between mouse erbB3 and wild-type rat c-neu transgenic mouse mammary tumor cells. Breast Cancer Res 7: R708-R718, 2005.
21. Sivaraman VS, Wang H, Nuovo GJ and Malbon CC: Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99: 1478-1483, 1997. (Pubitemid 27163797)
22. Loda M, Capodieci P, Mishra R, et al: Expression of mitogen-activated protein kinase phosphatase-1 in the early phase of human epithelial carcinogenesis. Am J Pathol 149: 1553-1564, 1996. (Pubitemid 26363962)
23. Maemura M, Iino Y, Koibuchi Y, Yokoe T and Morishita Y: Mitogen-activated protein kinase cascade in breast cancer. Oncology 57: 37-44, 1999. (Pubitemid 29494883)
24. Vizoso FJ, Gonzalez LO, Corte MD, et al: Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer 96: 903-911, 2007. (Pubitemid 46452295)
25. Tummalapalli P, Spomar D, Gondi CS, Olivero WC, Gujrati M, Dinh DH and Rao JS: RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. Int J Oncol 31: 1039-1050, 2007.
26. Zheng H, Takahashi H, Murai Y, et al: Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26: 3579-4383, 2006. (Pubitemid 44701542)
27. Hao L, Zhang C, Qiu Y, et al: Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 253: 34-42, 2007.
28. Li HC, Cao DC, Liu Y, et al: Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Res Treat 88: 75-85, 2004. (Pubitemid 39524447)